4.5 Article

Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Blockage of TNF-α by Infliximab Reduces CCL2 and CCR2 Levels in Patients With Rheumatoid Arthritis

Liping Xia et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2016)

Article Medicine, Research & Experimental

CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice

Yue Si et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Immunology

TNFR1-Dependent Regulation of Myeloid Cell Function in Experimental Autoimmune Uveoretinitis

Ben J. E. Raveney et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Ophthalmology

Development of Experimental Autoimmune Uveitis: Efficient Recruitment of Monocytes Is Independent of CCR2

Athanasios Dagkalis et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)

Article Ophthalmology

Local Ocular Immunomodulation Resulting from Electrotransfer of Plasmid Encoding Soluble TNF Receptors in the Ciliary Muscle

Laura Kowalczuk et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)

Article Immunology

Inflammatory molecules: A target for treatment of systemic autoimmune diseases

A. Tincani et al.

AUTOIMMUNITY REVIEWS (2007)

Review Biochemistry & Molecular Biology

How TNF was recognized as a key mechanism of disease

Ian A. Clark

CYTOKINE & GROWTH FACTOR REVIEWS (2007)

Article Ophthalmology

Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice

T Oshima et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2006)

Review Ophthalmology

The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU)

AD Dick et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2004)

Review Rheumatology

Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases

LG Criscione et al.

CURRENT OPINION IN RHEUMATOLOGY (2002)

Article Medicine, General & Internal

Drug-induced systemic lupus erythematosus associated with etanercept therapy

N Shakoor et al.

LANCET (2002)

Article Medicine, General & Internal

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent

J Keane et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Immunology

Tumor necrosis factor: a master-regulator of leukocyte movement

JD Sedgwick et al.

IMMUNOLOGY TODAY (2000)